Abstract
Breast cancer is the most common malignant tumor in women diagnosed globally and the leading cause of cancer-related death. Globally, the prevalence of breast cancer is increasing with time. Globally, breast cancer is the most prevalent type of cancer. The incidence of breast cancer is linked to several risk factors, such as genetic and inherited predispositions. Breast cancers can be of many different forms. The molecular features of breast cancer, such as the activation of hormone receptors (PR, ER, and HER2) and human epidermal growth factor receptor 2, genetic alterations (BRCA1/2 and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [PIK3CA] mutations), and immune system markers (PD L1, tumour-infiltrating lymphocytes [TIL], and programmed death-ligand 1 [PD L1]) may impact treatment strategies. sufferers.
Publisher
South Asian Academic Publications
Reference15 articles.
1. Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS. Male breast cancer: is the incidence increasing?. Annals of Surgical Oncology. 2004 Aug;11:751-5. https://pubmed.ncbi.nlm.nih.gov/15289238/
2. Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, Rosenblatt DN, Thune I, Vieira R, Norat T. Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies. Annals of oncology. 2014 Oct 1;25(10):1901-14.
3. Nardin S, Mora E, Varughese FM, D'Avanzo F, Vachanaram AR, Rossi V, Saggia C, Rubinelli S, Gennari A. Breast cancer survivorship, quality of life, and late toxicities. Frontiers in oncology. 2020 Jun 16;10:864.
4. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory. Cancer today. 2018;23(7):323-6.
5. Pisipati SV, Pathapati H, Bhukya G, Nuthakki S, Chandu B, Nama S, Adeps R. Lycopene: Redress for prostate cancer. Journal of Basic and Clinical Pharmacy. 2012 Mar;3(2):261.